Video

Mitigate Risk Of Virus Contaminations In Biopharma Manufacturing

sartorius

Virus contaminations of cell cultures can lead to the closure of biopharmaceutical manufacturing facilities. Franz Nothelfer of Boehringer Ingelheim explains, at the European Upstream & Downstream Forum 2016, why growth media filtration with a virus-retentive filter could become the only risk-mitigation method accepted by the regulatory authorities.

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: